bioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Growth in Short Interest

by · The Cerbat Gem

bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 260,000 shares, a growth of 100.9% from the March 31st total of 129,400 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 2,600.0 days. Approximately 0.2% of the company’s stock are short sold.

bioMérieux Price Performance

BMXMF stock remained flat at $130.75 during midday trading on Monday. bioMérieux has a 12 month low of $93.50 and a 12 month high of $131.75. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.20 and a current ratio of 2.21. The company’s fifty day simple moving average is $124.56 and its 200 day simple moving average is $115.16.

bioMérieux Company Profile

(Get Free Report)

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.

Read More